crosplum.blogg.se

Prolia ® is indicated as a treatment to increase bone mass in women at high riskįor fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Patients Prolia ® also reduced the incidence of vertebral fractures. Prolia ® is indicated as a treatment to increase bone mass in men at high risk forįracture receiving androgen deprivation therapy for nonmetastatic prostate cancer. High risk of fracture is defined asĪ history of osteoporotic fracture, multiple risk factors for fracture, or patients who haveįailed or are intolerant to other available osteoporosis therapy. Systemic glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone andĮxpected to remain on glucocorticoids for at least 6 months. In men and women at high risk of fracture who are either initiating or continuing Prolia ® is indicated for the treatment of glucocorticoid-induced osteoporosis Or multiple risk factors for fracture or patients who have failed or are intolerant to other Osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, Prolia ® is indicated for treatment to increase bone mass in men with Postmenopausal women with osteoporosis, Prolia ® reduces the incidence of

Indicated for the treatment of postmenopausal women with osteoporosis at high risk forįracture, defined as a history of osteoporotic fracture, or multiple risk factors forįracture or patients who have failed or are intolerant to other available osteoporosis therapy.